Read Financial Articles on Day Trading, Investment, Stock Market, NIFTY, BSE, NSE, Mutual Fund, Commodities and ETF
JACKPOT PACKAGE: Get 95%+ Accuracy in our premium package. Charges only Rs.5000/Month.
To Get Free Trial Just SMS JACKPOT and your Name to 9999961207 or Call Us.
Share Gyan launches new website for COMMODITY TIPS. Register for free trial @ CommodityGyan.in now!


New state-of-art research centre pushes up the stock of Navin Fluorine

Monday, January 5, 2009 12:38 pm
By ShareGyan.com NewsDesk

Navin Fluorine International presently trades at Rs 139.50, up by 6.60 points or 4.97% from its previous closing of Rs 132.90 on the BSE. The stock opened on the lower side at Rs 132.80 and has touched a high of Rs 140 and a low of Rs 132.80. So far, 12,207 shares were traded on the BSE.

The Small-Cap Stock has touched a 52 week high of Rs 455 and a 52 week low of Rs 103.

Navin Fluorine International has disclosed its new state-of-the-art research and innovation centre developed at its plant located at Bhestan, Surat.

The centre christened Navin Research & Innovation Centre (NRIC) is well equipped with the latest sophisticated equipments to cater to the growing needs of pharmaceutical and agrochemical sectors and is spread over 25,000 square feet of area. The facility also covers a pilot plant to carry out trials on processes developed in the centre.

Navin Fluorine is one of the world’s largest integrated specialty fluorochemical companies that offer a wide range of products. Many top global agrochemical and Indian pharmaceutical companies are working with this company for their specialty fluorochemicals needs

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Copyright © 2009 ShareGyan.com. All rights reserved.

Disclaimer: Trading or investing in stocks & commodities is a high risk activity. Any action you choose to take in the markets is totally your own responsibility. ShareGyan.com will not be liable for any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information.

Disclosure: The information on this website is neither an offer to sell nor solicitation to buy any of the securities mentioned herein. The writers may or may not be trading in the securities mentioned.